Počet záznamov: 1
haloperidol
SYS d006220 LBL 00000nz--a2200000o--4500 005 20260512091024.5 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.522.352.506 066 $a 01 $c 03 150 $a haloperidol $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000932 $Y Antiemetics $w P $a antiemetiká 550 $7 sllk_us_auth*d014150 $Y Antipsychotic Agents $w P $a antipsychotiká 550 $7 sllk_us_auth*d018492 $Y Dopamine Antagonists $w P $a antagonisty dopamínu 550 $7 sllk_us_auth*d018726 $Y Anti-Dyskinesia Agents $w P $a antidyskinetiká 680 9-
$i A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) $2 eng 750 -2
$a Haloperidol $2 eng 980 $x M
Počet záznamov: 1